Log in to save to my catalogue

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9199453

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

About this item

Full title

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2016-09, Vol.17 (9), p.1317-1324

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background A subset of patients with metastatic renal-cell carcinoma show indolent growth of metastases. Because of the toxicity and non-curative nature of systemic therapy, some of these patients could benefit from initial active surveillance. We aimed to characterise the time to initiation of systemic therapy in patients with metastatic r...

Alternative Titles

Full title

Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9199453

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9199453

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(16)30196-6

How to access this item